Genetic polymorphisms in the important TLR genes especially TLR2 and TLR4 do have an effective modulatory bearing on the susceptibility to CRC, which is important in deducing them as one of the biomarkers for this malignancy. This evidence concerns the gene TLR4 and colorectal carcinoma.